X-linked reticulate pigmentary disorder

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:85453OMIM:301220E85.0+L99.0*
Who is this for?
Show terms as
1FDA treatments10Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jan 2026New Pattern of Retinal Laser Treatment for PDR

Eye & ENT Hospital of Fudan University — NA

TrialNOT YET RECRUITING
Dec 2025High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

Edward Wood, MD — PHASE4

TrialACTIVE NOT RECRUITING
Aug 2025Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

Jaeb Center for Health Research — PHASE3

TrialRECRUITING
Jun 2025Fovea Sparing ILM Peeling in Diabetic Patients

David Nashaat Shafik Fahmy — NA

TrialACTIVE NOT RECRUITING
Apr 2025Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

University Hospital, Basel, Switzerland — PHASE1

TrialRECRUITING
Feb 2025Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

Fundacion Clinic per a la Recerca Biomédica — PHASE2

TrialACTIVE NOT RECRUITING
Nov 2024Integration to Improve Adolescent Health and HPV Vaccination in Laos

Health Poverty Action — NA

TrialRECRUITING
Dec 2023The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

Li Xiaorong — EARLY_PHASE1

TrialRECRUITING
Aug 2022Social Transfers for Exclusive Breastfeeding

Swiss Tropical & Public Health Institute — NA

TrialACTIVE NOT RECRUITING
Jul 2022Drug Discovery for Parkinson's With Mutations in the GBA Gene

New York Stem Cell Foundation Research Institute — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

DHIVY

CARBIDOPA LEVODOPA· Avion Pharmaceuticals, LLC

indicated for the treatment of Parkinson's disease

No actively recruiting trials found for X-linked reticulate pigmentary disorder at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked reticulate pigmentary disorder community →

Specialists

10 foundView all specialists →
PZ
Peiquan Zhao
Specialist
PI on 2 active trials102 X-linked reticulate pigmentary disorder publications
RM
Robert B Innis, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 8 active trials
BP
Bastiaan R Bloem, MD, PhD
Nijmegen
Specialist

Rare Disease Specialist

PI on 2 active trials
TP
Travis B. Lewis, MD, PhD
Scottsdale, Arizona
Specialist

Rare Disease Specialist

MM
Michele Matarazzo, MD
Portland, Oregon
Specialist

Rare Disease Specialist

JP
James Beck, PhD
Birmingham, Alabama
Specialist

Rare Disease Specialist

LA
Laura Andres-Martin
New York, New York
Specialist

Rare Disease Specialist

PI on 3 active trials1 X-linked reticulate pigmentary disorder publication
VP
Veronique Vanderhorst, MD PhD
Boston, Massachusetts
Specialist

Rare Disease Specialist

OM
Orla Mitchell
London
Specialist

Rare Disease Specialist

AV
Anna S Vergmann
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

National Institutes of Health Clinical Center

📍 Bethesda, Maryland

👤 Payal P Khincha, M.D.

👤 Christopher Grunseich, M.D.

⚗️ Trial Site

University of Florida

📍 Gainesville, Florida

👤 Richard Neibeger, MD

⚗️ Trial Site

Northwestern University

📍 Chicago, Illinois

👤 Ann (Annie) W Silk

⚗️ Trial Site

University of Chicago

📍 Chicago, Illinois

⚗️ Trial Site

Oregon Health & Science University

📍 Portland, Oregon

⚗️ Trial Site

University of Miami

📍 Miami, Florida

⚗️ Trial Site

University of Washington

📍 Seattle, Washington

👤 Janssen Research & Development, LLC Clinical Trial

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

Financial Resources

1 resources

CARBIDOPA, LEVODOPA, AND ENTACAPONE

Sandoz Inc

CARBIDOPA, LEVODOPA, AND ENTACAPONE — Contact Sandoz Inc

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to X-linked reticulate pigmentary disorder.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked reticulate pigmentary disorderForum →

No community posts yet. Be the first to share your experience with X-linked reticulate pigmentary disorder.

Start the conversation →

Latest news about X-linked reticulate pigmentary disorder

Disease timeline:

New recruiting trial: Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

A new clinical trial is recruiting patients for X-linked reticulate pigmentary disorder

New recruiting trial: The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

A new clinical trial is recruiting patients for X-linked reticulate pigmentary disorder

New recruiting trial: Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

A new clinical trial is recruiting patients for X-linked reticulate pigmentary disorder

New recruiting trial: Integration to Improve Adolescent Health and HPV Vaccination in Laos

A new clinical trial is recruiting patients for X-linked reticulate pigmentary disorder

New trial: Parkinson's Foundation PD GENEration Genetic Registry

Phase NA trial recruiting. Lab Assay for seven genetic variants for Parkinson's Disease

New trial: Gait Analysis in Neurological Disease

Phase NA trial recruiting. Anti-Parkinson medication

New trial: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Phase PHASE1 trial recruiting. 11C-MC1

New trial: Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least On

Phase PHASE1 trial recruiting. LY3884961

New trial: PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

Phase NA trial recruiting.

New trial: The GBA Multimodal Study in Parkinson's Disease

Phase NA trial recruiting. PET scan

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked reticulate pigmentary disorder

Which specialists treat X-linked reticulate pigmentary disorder?

10 specialists and care centers treating X-linked reticulate pigmentary disorder are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for X-linked reticulate pigmentary disorder?

1 patient support program are currently tracked on UniteRare for X-linked reticulate pigmentary disorder. See the treatments and support programs sections for copay assistance, eligibility, and contact details.